Reply to: "Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis"

• Type of Material: Article
• Authors: Iviensan F. Manalo, Emory University; Molly K. Smith, Pariser Dermatol Specialists; Justin Cheeley, Emory University; Randy Jacobs, University of California Riverside
• Language: English
• Date: 2020-08-01
• Publisher: MOSBY-ELSEVIER
• Publication Version: Final Published Version
• Copyright Statement: © 2020 by the American Academy of Dermatology, Inc.
• Final Published Version (URL): http://dx.doi.org/10.1016/j.jaad.2020.05.001
• Title of Journal or Parent Work: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
• Volume: 83
• Issue: 2
• Start Page: E157
• End Page: E157
• Grant/Funding Information: None
• Keywords: Life Sciences & Biomedicine; Science & Technology; Dermatology
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

To the Editor: We appreciate the additional information from Dr Christina Thomas1 on our report2 of transient livedo reticularis occurring in patients with COVID-19. Dr Thomas astutely notes that disseminated intravascular coagulation and macrothromboses appear to be more prominent in severely ill COVID-19 populations and that other potential factors, such as inflammatory cytokines or the viral mechanism of binding to angiotensin-converting enzyme 2, may play a role in microthrombi formation in less severe disease.